MetLife Investment Management’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $74.5M | Sell |
348,574
-13,063
| -4% | -$2.92M | 0.38% | 33 |
|
|
2025
Q4 | $61.9M | Sell |
361,637
-13,148
| -4% | -$2.04M | 0.3% | 40 |
|
|
2025
Q3 | $50.2M | Sell |
374,785
-9,337
| -2% | -$989K | 0.24% | 52 |
|
|
2025
Q2 | $37.4M | Sell |
384,122
-5,294
| -1% | -$420K | 0.22% | 67 |
|
|
2025
Q1 | $28.3M | Sell |
389,416
-7,802
| -2% | -$614K | 0.15% | 99 |
|
|
2024
Q4 | $28.7M | Sell |
397,218
-1,362
| -0.3% | -$103K | 0.16% | 94 |
|
|
2024
Q3 | $32.5M | Sell |
398,580
-10,750
| -3% | -$935K | 0.19% | 84 |
|
|
2024
Q2 | $43.6M | Buy |
409,330
+50,680
| +14% | +$4.86M | 0.26% | 55 |
|
|
2024
Q1 | $34.8M | Sell |
358,650
-12,640
| -3% | -$1.11M | 0.23% | 66 |
|
|
2023
Q4 | $29.1M | Sell |
371,290
-11,540
| -3% | -$786K | 0.21% | 78 |
|
|
2023
Q3 | $24M | Sell |
382,830
-11,080
| -3% | -$728K | 0.19% | 88 |
|
|
2023
Q2 | $25.3M | Sell |
393,910
-8,120
| -2% | -$458K | 0.18% | 94 |
|
|
2023
Q1 | $21.3M | Sell |
402,030
-8,740
| -2% | -$429K | 0.15% | 106 |
|
|
2022
Q4 | $17.3M | Sell |
410,770
-9,610
| -2% | -$402K | 0.13% | 126 |
|
|
2022
Q3 | $15.4M | Sell |
420,380
-10,090
| -2% | -$449K | 0.13% | 128 |
|
|
2022
Q2 | $18.3M | Sell |
430,470
-12,300
| -3% | -$586K | 0.14% | 117 |
|
|
2022
Q1 | $23.8M | Buy |
442,770
+131,670
| +42% | +$7.67M | 0.15% | 104 |
|
|
2021
Q4 | $22.4M | Sell |
311,100
-10,760
| -3% | -$675K | 0.18% | 93 |
|
|
2021
Q3 | $18.3M | Sell |
321,860
-8,800
| -3% | -$535K | 0.16% | 106 |
|
|
2021
Q2 | $21.5M | Sell |
330,660
-9,900
| -3% | -$625K | 0.19% | 92 |
|
|
2021
Q1 | $20.3M | Sell |
340,560
-9,180
| -3% | -$500K | 0.19% | 95 |
|
|
2020
Q4 | $16.5M | Sell |
349,740
-19,490
| -5% | -$820K | 0.16% | 114 |
|
|
2020
Q3 | $12.2M | Sell |
369,230
-10,430
| -3% | -$359K | 0.13% | 141 |
|
|
2020
Q2 | $12.3M | Buy |
379,660
+5,700
| +2% | +$155K | 0.14% | 139 |
|
|
2020
Q1 | $8.98M | Sell |
373,960
-11,440
| -3% | -$329K | 0.12% | 156 |
|
|
2019
Q4 | $11.3M | Sell |
385,400
-7,930
| -2% | -$211K | 0.12% | 164 |
|
|
2019
Q3 | $9.09M | Sell |
393,330
-19,930
| -5% | -$418K | 0.1% | 190 |
|
|
2019
Q2 | $7.76M | Sell |
413,260
-20,510
| -5% | -$389K | 0.08% | 214 |
|
|
2019
Q1 | $7.76M | Sell |
433,770
-10,020
| -2% | -$167K | 0.08% | 210 |
|
|
2018
Q4 | $6.04M | Sell |
443,790
-14,620
| -3% | -$210K | 0.07% | 239 |
|
|
2018
Q3 | $6.95M | Sell |
458,410
-24,500
| -5% | -$418K | 0.07% | 246 |
|
|
2018
Q2 | $8.35M | Sell |
482,910
-7,480
| -2% | -$144K | 0.1% | 181 |
|
|
2018
Q1 | $9.96M | Sell |
490,390
-10,690
| -2% | -$212K | 0.12% | 169 |
|
|
2017
Q4 | $9.22M | Buy |
+501,080
| New | +$9.85M | 0.1% | 176 |
|
Other funds holding LRCX
VCM
VPM
MetLife Investment Management's LRCX Position: Q1 2026 in Review
MetLife Investment Management reduced its Lam Research (LRCX) stake by 3.6% in Q1 2026, selling an estimated $2.92M and leaving 348,574 shares worth $74.5M. The position accounts for 0.38% of the portfolio, ranked #33.
MetLife Investment Management first reported a position in LRCX in Q4 2017 and has held it in 34 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.
- MetLife Investment Management held 348,574 shares of Lam Research worth $74.5M as of Q1 2026.
- MetLife Investment Management sold 13,063 Lam Research shares in Q1 2026, an estimated $2.92M.
- Lam Research made up 0.38% of MetLife Investment Management's portfolio in Q1 2026, its #33 holding.
- MetLife Investment Management first reported a position in Lam Research in Q4 2017 and has held it in 34 quarters since.
- 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.